You have 9 free searches left this month | to do more

gm-csf

Gm Csf is a drug used to treat Lymphoma, Neuroblastoma, Breast Cancer, and other conditions. Gm Csf is being actively studied in 21 studies and prior, has been studied in 35.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterBeth Israel Deaconess Medical CenterMark Hall
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer InstituteRita Sanghvi, Mehta
National Cancer Institute (NCI)Memorial Sloan Kettering Cancer CenterArshed A. Quyyumi
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients - 2016
Completed
Has Results
  • Metastatic Melanoma
  • Louisville, Kentucky
    James Graham Brown Cancer Center
2021-10-22
Oct 22, 2021
N
GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study
Active, not recruiting
  • Pediatric Sepsis-induced MODS
  • GM-CSF
  • Los Angeles, California
  • +7 more
2022-02-24
Feb 24, 2022
M
GM-CSF for Immunomodulation Following Trauma (GIFT) Study - 2022
Completed
  • Critical Injury (Trauma) in Children
  • GM-CSF
  • Aurora, Colorado
  • +7 more
2022-02-24
Feb 24, 2022
M
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
Recruiting
  • Neuroblastoma
  • β-glucan
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2022-03-11
Mar 11, 2022
S
Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0)
Recruiting
  • Advanced Refractory Solid Tumors
  • Hypofractionated radiotherapy
  • +3 more
  • Beijing, China
  • +15 more
2021-08-30
Aug 30, 2021
E
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
Recruiting
  • Peripheral Artery Disease (PAD)
  • GM-CSF
  • Placebo
  • Atlanta, Georgia
    Emory University Hospital
2021-10-08
Oct 8, 2021
M
A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma
Active, not recruiting
  • Neuroblastoma
  • Hu3F8
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-12-13
Dec 13, 2021
B
Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod
Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • GM-CSF
  • +2 more
  • Boston, Massachusetts
  • +3 more
2022-01-25
Jan 25, 2022
M
Study of Chemoimmunotherapy for High-Risk Neuroblastoma
Active, not recruiting
  • Neuroblastoma (NB)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-10-19
Oct 19, 2021
T
Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC
Recruiting
  • Colorectal Neoplasms
  • hypofractionation Radiotherapy
  • +3 more
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
2022-03-28
Mar 28, 2022
N
GM-CSF for Reversal of Immunoparalysis in Pediatric Sepsis-induced MODS
Not yet recruiting
  • Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome
  • GM-CSF
  • Placebo
  • Little Rock, Arkansas
  • +25 more
2022-03-02
Mar 2, 2022
N
Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma - 2021
Completed
  • Mantle Cell Lymphoma
  • Lymphoma, Mantle Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-03-24
Mar 24, 2022
M
Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma
Recruiting
  • Recurrent Osteosarcoma
  • humanized anti-GD2 antibody
  • GM-CSF
  • Los Angeles, California
  • +2 more
2021-11-18
Nov 18, 2021
M
Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma - 2016
Completed
Has Results
  • Melanoma
  • GM-CSF
  • Standard of Care
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2020-01-29
Jan 29, 2020
G
Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma
Suspended
  • Glioblastoma
  • Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
  • +4 more
  • Durham, North Carolina
    Duke University Medical Center
2021-09-21
Sep 21, 2021
U
UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma
Active, not recruiting
  • Malignant Melanoma
  • Santa Monica, California
  • +3 more
2021-05-20
May 20, 2021
U
ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme
Active, not recruiting
  • Glioblastoma
  • Gliosarcoma
  • Orange, California
  • +2 more
2021-07-20
Jul 20, 2021
C
Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients - 2021
Completed
  • Breast Cancer
  • NeuVax vaccine
  • +2 more
  • Santa Monica, California
  • +23 more
2022-02-28
Feb 28, 2022
I
IBI188 Combination Therapy in Solid Tumors
Recruiting
  • Solid Tumors
  • +2 more
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
2021-07-18
Jul 18, 2021
U
pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer
Active, not recruiting
  • Prostate Cancer
  • pTVG-HP
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
2022-02-07
Feb 7, 2022
F
SBRT in Combination With Sintilimab and GM-CSF for the Treatment of Advanced NSCLC
Recruiting
  • NSCLC Stage IV
  • GM-CSF
  • +2 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
2019-09-25
Sep 25, 2019
Y
Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission.
Recruiting
  • Neuroblastoma
  • Kowloon, Hong Kong
  • +8 more
2022-01-31
Jan 31, 2022
U
Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma
Active, not recruiting
  • Malignant Melanoma
  • Oslo, Norway
    Oslo University Hospital, Radiumhospitalet
2021-05-14
May 14, 2021
S
Therapy for Children With Advanced Stage Neuroblastoma
Active, not recruiting
  • Neuroblastoma
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
2022-01-05
Jan 5, 2022
G
First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699 - 2019
Terminated
Has Results
  • Arthritis, Rheumatoid
  • Placebo
  • +4 more
  • Cambridge, United Kingdom
    GSK Investigational Site
2020-11-06
Nov 6, 2020